Literature DB >> 15504357

Involvement of C/EBP-alpha gene in in vitro activation of rat hepatic stellate cells.

Guang-Cun Huang1, Jin-Sheng Zhang, Qi-Qun Tang.   

Abstract

Hepatic stellate cells (HSCs) play key roles in hepatic fibrosis. One of the most striking alterations in activated HSCs is loss of cytoplasmic lipid droplets. However, the association of lipid storage with the activation of HSCs remains unclear. CCAAT/enhancer-binding proteins family (C/EBPs), especially C/EBP-alpha, controls differentiation of adipocytes. We suggested that C/EBP-alpha gene may be involved in HSCs activation. The present results showed that the expression levels of C/EBP-alpha and C/EBP-beta genes declined in activated HSCs. Over-expression of C/EBP-alpha gene in activated HSCs: (1) inhibited HSCs proliferation, extracellular matrix-producing, alpha-smooth muscle actin gene expression, and induced rebound of cytoplasmic lipid droplets; (2) reduced retinoic acid receptor-beta, C/EBP-delta and -beta gene expressions, but increased the active form C/EBP-beta PSer(105), and induced retinoid X receptor-alpha gene expression; and (3) did not affect the protein level of p16INK4a, p21Cip1/WAF1 or p27Kip1. In conclusions, C/EBP-alpha gene is involved in in vitro activation of rat HSCs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504357     DOI: 10.1016/j.bbrc.2004.09.196

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Daily genetic profiling indicates JAK/STAT signaling promotes early hepatic stellate cell transdifferentiation.

Authors:  Ashley M Lakner; Cathy C Moore; Alyssa A Gulledge; Laura W Schrum
Journal:  World J Gastroenterol       Date:  2010-10-28       Impact factor: 5.742

Review 2.  Mechanisms of hepatic fibrogenesis.

Authors:  Ursula E Lee; Scott L Friedman
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-04       Impact factor: 3.043

3.  Mulberry leaves (Morus alba L.) ameliorate obesity-induced hepatic lipogenesis, fibrosis, and oxidative stress in high-fat diet-fed mice.

Authors:  Ji-Young Ann; Hyeyoon Eo; Yunsook Lim
Journal:  Genes Nutr       Date:  2015-10-13       Impact factor: 5.523

4.  Impaired balance of T helper 17/T regulatory cells in carbon tetrachloride-induced liver fibrosis in mice.

Authors:  Xiao-Fei Sun; Lei Gu; Wen-Sheng Deng; Qing Xu
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

5.  Pattern analysis uncovers a chronic ethanol-induced disruption of the switch-like dynamics of C/EBP-β and C/EBP-α genome-wide binding during liver regeneration.

Authors:  Lakshmi Kuttippurathu; Biswanath Patra; Daniel Cook; Jan B Hoek; Rajanikanth Vadigepalli
Journal:  Physiol Genomics       Date:  2016-11-04       Impact factor: 3.107

6.  The effect of APTR, Fn14 and CD133 expressions on liver fibrosis in biliary atresia patients.

Authors:  Akhmad Makhmudi; Reinaldo Supanji; Bayu Pratama Putra
Journal:  Pediatr Surg Int       Date:  2019-09-23       Impact factor: 1.827

7.  Trichostatin A inhibits the activation of Hepatic stellate cells by Increasing C/EBP-α Acetylation in vivo and in vitro.

Authors:  Di Ding; Lin-Lin Chen; Ying-Zhen Zhai; Chen-Jian Hou; Li-Li Tao; Shu-Han Lu; Jian Wu; Xiu-Ping Liu
Journal:  Sci Rep       Date:  2018-03-13       Impact factor: 4.379

8.  Lipopolysaccharide Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against Decapentaplegic, and CCAAT/Enhancer-Binding Protein C/EBP Transcription Factors.

Authors:  Akanksha Sharma; Alok K Verma; Matthew Kofron; Ramesh Kudira; Alexander Miethke; Tong Wu; Jiang Wang; Chandrashekhar R Gandhi
Journal:  Hepatology       Date:  2020-10-22       Impact factor: 17.298

9.  Rapamycin ameliorates CCl4-induced liver fibrosis in mice through reciprocal regulation of the Th17/Treg cell balance.

Authors:  Lei Gu; Wen-Sheng Deng; Xiao-Fei Sun; Hong Zhou; Qing Xu
Journal:  Mol Med Rep       Date:  2016-06-10       Impact factor: 2.952

Review 10.  Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?

Authors:  Alex Claveria-Cabello; Leticia Colyn; Maria Arechederra; Jesus M Urman; Carmen Berasain; Matias A Avila; Maite G Fernandez-Barrena
Journal:  Cells       Date:  2020-10-19       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.